Factors leading to the late diagnosis and poor outcomes of breast cancer in Matabeleland South and the Bulawayo Metropolitan Provinces in Zimbabwe.

Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

Original Publication: San Francisco, CA : Public Library of Science

Delayed Diagnosis* ; Breast Neoplasms*/diagnosis ; Breast Neoplasms*/epidemiology; Humans ; Female ; Zimbabwe/epidemiology ; Focus Groups ; Qualitative Research

Introduction: Breast cancer (BC) is the leading cause of female cancer deaths in Africa, and in Zimbabwe, >80% present with advanced disease. A Needs Project (NP) was carried out to determine the key factors responsible for delayed diagnosis and poor BC outcomes and to investigate possible solutions in 6 rural and urban districts of Matabeleland South and Bulawayo Metropolitan Provinces.
Methods: A mixed method approach was used to collect data in 2 phases. Phase 1: an exploration of key factors leading to poor BC outcomes with >50 professional stakeholders and patient representatives. Phase 2: (i) Quantitative arm; validated questionnaires recording breast cancer knowledge, demographic information and perceived barriers to care administered to women and their relatives (Group 1) and health professionals (HPs) (Group 2). (ii) Qualitative arm; 10 focus group discussions with medical specialists and interested lay representatives (Group 3). The Cochran sample size formulae technique was used to determine the quantitative sample size and data was aggregated and analysed using SPSS Version 23™. Purposive sampling for the qualitative study selected participants with an understanding of BC and the NP. Focus group discussions were recorded and a thematic analysis of the transcriptions was conducted using NVivo9™.
Results: Quantitative analysis of Group 1 data (n = 1107) confirmed that younger women (<30years) had the least knowledge of breast cancer (p<0.001). Just under half of all those surveyed regarded breast cancer as incurable. In Group 2 (n = 298) the largest group of health workers represented were general nurses and midwives (74.2%) in keeping with the structure of health provision in Zimbabwe. Analysis confirmed a strong association between age and awareness of BC incidence (p = 0.002) with respondents aged 30-39 years being both the largest group represented and the least knowledgeable, independent of speciality. Nearly all respondents (90%) supported decentralisation of appropriate breast surgical services to provincial and district hospitals backed up by specialist training. Thematic analysis of focus group discussions (Group 3) identified the following as important contributors to late BC diagnosis and poor outcomes: (i) presentation is delayed by poorly educated women and their families who fear BC and high treatment costs (ii) referral is delayed by health professionals with no access to training, skills or diagnostic equipment (iii), treatment is delayed by a disorganised, over-centralized patient pathway, and a lack of specialist care and inter-disciplinary communication.
Conclusion: This study confirms that the reasons for poor BC outcomes in Zimbabwe are complex and multi-factorial. All stakeholders support better user and provider education, diagnostic service reconfiguration, targeted funding, and specialist training.
Competing Interests: The authors have declared that no competing interests exist.
(Copyright: © 2023 Magara et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)

Afr J Prim Health Care Fam Med. 2017 Nov 28;9(1):e1-e2. (PMID: 29227136)
Global Health. 2019 Jan 8;15(1):3. (PMID: 30621753)
Infect Agent Cancer. 2017 Feb 14;12:13. (PMID: 28228841)
Int J Cancer. 2010 Dec 15;127(12):2893-917. (PMID: 21351269)
Sci Rep. 2019 Jul 15;9(1):10158. (PMID: 31308467)
Oncologist. 2015 Jul;20(7):780-8. (PMID: 26032138)
BMJ Open. 2019 Aug 26;9(8):e028705. (PMID: 31455705)
Cien Saude Colet. 2015 Oct;20(10):3177-89. (PMID: 26465859)
Int J Cancer. 2014 Nov 1;135(9):2173-82. (PMID: 24658866)
Ann Epidemiol. 2017 Oct;27(10):659-671.e7. (PMID: 29128086)
CA Cancer J Clin. 2018 Nov;68(6):394-424. (PMID: 30207593)
Breast Cancer Res. 2019 Aug 13;21(1):93. (PMID: 31409419)
Lancet Glob Health. 2020 Sep;8(9):e1203-e1212. (PMID: 32827482)
Indian J Med Paediatr Oncol. 2017 Jul-Sep;38(3):277-281. (PMID: 29200673)
BMC Cancer. 2009 Jun 25;9:203. (PMID: 19555506)
World J Surg Oncol. 2018 Mar 22;16(1):63. (PMID: 29566711)
J R Coll Surg Edinb. 1993 Apr;38(2):75-8. (PMID: 8478837)
J Ayub Med Coll Abbottabad. 2018 Oct-Dec;30(4):558-561. (PMID: 30632337)
BMJ Open. 2016 Jan 04;6(1):e009905. (PMID: 26729392)
Glob Public Health. 2015;10(3):331-44. (PMID: 25443995)
Breast Cancer Res. 2004;6(6):229-39. (PMID: 15535852)
Sci Rep. 2020 Dec 8;10(1):21477. (PMID: 33293634)
Int J Cancer. 2020 Mar 1;146(5):1208-1218. (PMID: 31087650)
J Epidemiol. 2014;24(2):102-8. (PMID: 24335087)
BMC Public Health. 2021 Jul 6;21(1):1325. (PMID: 34229634)
Womens Health (Lond). 2016 Jan;12(1):147-56. (PMID: 26757491)
Int J Cancer. 2015 Jun 15;136(12):2875-9. (PMID: 25408458)

Date Created: 20231103 Date Completed: 20231106 Latest Revision: 20231106

20231215

PMC10624273

10.1371/journal.pone.0292169

37922284